Richard Christopher - SEC Form 4 Insider Trading Activity

Summary

Updated Aug 3, 2026

Richard Christopher is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $132K. Historical track record: 2/5 stars across 3 tracked purchases.

Profile

Richard Christopher is the Chief Executive Officer at Lexaria Bioscience Corp. (LEXX). Christopher has reported 3 insider filings with the SEC since 2024. The most recent filing was in July 2025.

RoleChief Executive Officer, Director
Notability40/100

Board memberships

Reported roles

Awards & honors

Track Record

InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.

InsiderAlpha rating★★☆☆☆ (2/5)
Total purchases tracked3
Purchases with forward-return data3
30-day win rate67%
90-day win rate33%
Avg 5-day return-1.58%
Avg 30-day return-4.01%
Avg 90-day return-27.66%
Best 30-day return+2.68%

Trading Pattern

InsiderAlpha's records for Richard Christopher go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. The typical open-market purchase is $44K (3 buys totaling $132K). The largest single buy on record is $67K of LEXX in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.

Career & Filing History

Every role Richard Christopher has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2025-07-30LEXXLexaria Bioscience Corp.P - Open-market purchase15.0K$0.91$14K
2024-12-03LEXXLexaria Bioscience Corp.P - Open-market purchase27.2K$2.47$67K
2024-12-03LEXXLexaria Bioscience Corp.P - Open-market purchase22.8K$2.24$51K

Most Active Insiders Right Now

Richard Christopher has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.

More Notable Insiders

Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:

Frequently Asked Questions

Who is Richard Christopher?

Richard Christopher is the Chief Executive Officer at Lexaria Bioscience Corp. (LEXX). Christopher has reported 3 insider filings with the SEC since 2024. The most recent filing was in July 2025.…

Has Richard Christopher been buying or selling stock?

Recorded transactions: 3 open-market purchases ($132K) and 0 open-market sales across all tracked filings.

How accurate is Richard Christopher's historical track record?

Across 3 tracked purchases, Richard Christopher averaged -4.0% avg 30-day return with a 67% 30-day win rate. InsiderAlpha rates the track record at 2/5 stars.

Where can I see all of Richard Christopher's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Richard Christopher profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.